Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAU | P00749 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.40 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.40 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | PKM | P14618 | 2/20 | 0.38 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.38 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.38 |
| ▸ | PAK4 | O96013 | 1/20 | 0.38 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.38 |
| ▸ | LTK | P29376 | 1/20 | 0.38 |
| ▸ | MAP2K2 | P36507 | 1/20 | 0.38 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.38 |
| ▸ | CDK8 | P49336 | 1/20 | 0.38 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.38 |
| ▸ | PRKX | P51817 | 1/20 | 0.38 |
| ▸ | NEK2 | P51955 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL242787 | 0.83 | ALDH1A1 (0.48) | PLAUKDM4EALDH1A1HPGDPDPK1 | |
| SCHEMBL9939034 | 0.82 | ESR1 (0.52) | ESR1ABL1BCR | |
| SCHEMBL9171831 | 0.81 | ALDH1A1 (0.47) | PLAUKDM4EALDH1A1HPGDPDPK1 | |
| Water SCHEMBL7451096 | 0.81 | ALDH1A1 (0.47) | PLAUKDM4EALDH1A1HPGDPDPK1 | |
| SCHEMBL2611832 | 0.74 | KMT2A (0.43) | KDM4EALDH1A1HPGDGAACBFB | |
| SCHEMBL4104023 | 0.74 | METAP2 (0.44) | ALDH1A1PDPK1ESR1CHEK1FLT3 | |
| SCHEMBL735804 | 0.74 | PRKCI (0.48) | PLAUKDM4EALDH1A1HPGDPKM | |
| SCHEMBL2005551 | 0.74 | ALDH1A1 (0.46) | KDM4EALDH1A1HPGDTSHRCBFB | |
| SCHEMBL12871076 | 0.74 | — | — | |
| SCHEMBL2145072 | 0.74 | NOS1 (0.39) | PARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5763615-A | Methods for the preparation of benzyloxy benzotriazole herbicidal agents | AMERICAN CYANAMID COMPANY (US) | 1998-06-09 | — | — | US | claimed |
| US-5686617-A | RING CLOSURE, HYDROGENATION, ETHERIFICATION | AMERICAN CYANAMID COMPANY (US) | 1997-11-11 | — | — | US | claimed |
| US-20260133115-A1 | MASS CYTOMETRY REAGENTS AND METHODS FOR SIGNAL AMPLIFICATION | STANDARD BIOTOOLS CANADA INC. (CA) | 2026-05-14 | — | — | US | disclosed |
| US-12540893-B2 | Mass cytometry reagents and methods for signal amplification | STANDARD BIOTOOLS CANADA INC. (CA) | 2026-02-03 | — | — | US | disclosed |
| US-20250353855-A1 | HETEROCYCLIC AND HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE | PTC THERAPEUTICS INC (US) | 2025-11-20 | — | — | US | disclosed |
| CN-111454718-B | Ultrasensitive chemiluminescent substrates for peroxidases | 喜雅纳肯有限公司 | 2025-01-03 | — | — | CN | disclosed |
| CN-110208540-B | Methods and compositions for the detection and treatment of preeclampsia | 耶鲁大学 | 2024-02-09 | — | — | CN | disclosed |
| US-20230417755-A1 | ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR PEROXIDASE | CYANAGEN S R L (IT) | 2023-12-28 | — | — | US | disclosed |
| EP-3686285-B1 | ULTRA-SENSITIVE CHEMILUMINESCENT SUBSTRATES FOR PEROXIDASE | CYANAGEN S R L (IT) | 2023-10-11 | — | — | EP | disclosed |
| US-11761964-B2 | Ultra-sensitive chemiluminescent substrates for peroxidase | CYANAGEN S.R.L. (IT) | 2023-09-19 | — | — | US | disclosed |
| US-20230236105-A1 | MASS CYTOMETRY REAGENTS AND METHODS FOR SIGNAL AMPLIFICATION | STANDARD BIOTOOLS CANADA INC. (CA) | 2023-07-27 | — | — | US | disclosed |
| US-5686617-A | RING CLOSURE, HYDROGENATION, ETHERIFICATION | AMERICAN CYANAMID COMPANY (US) | 1997-11-11 | — | — | US | disclosed |
| CN-1149583-A | Enderma agent receptor antagonist | MERCK PATENT GMBH (DE) | 1997-05-14 | — | — | CN | disclosed |
| EP-0758650-A1 | Endothelin receptor antagonists | MERCK PATENT GmbH (DE) | 1997-02-19 | — | — | EP | disclosed |
| US-5428003-A | Aryloxy benzotriazole herbicidal agents and methods for the preparation thereof | AMERICAN CYANAMID COMPANY (US) | 1995-06-27 | — | — | US | disclosed |
| US-5324711-A | Aryloxy benzotriazole herbicidal agents and methods for the preparation thereof | AMERICAN CYANAMID COMPANY (US) | 1994-06-28 | — | — | US | disclosed |
| EP-0367242-A2 | Aryloxy benzotriazole herbicidal agents and methods for the preparation thereof | AMERICAN CYANAMID COMPANY (US) | 1990-05-09 | — | — | EP | disclosed |
| US-4297431-A | POLYMERS OF ACRYLIC ESTERS AS OVERCOATS OR TIMING LAYERS FOR LIGHT SENSITIVE ELEMENTS | POLAROID CORPORATION (US) | 1981-10-27 | — | — | US | disclosed |
| US-4220694-A | TRIAZOLE-COATED NEGATIVE ELECTRODE COLLECTOR | HITACHI MAXELL, LTD. (JP) | 1980-09-02 | — | — | US | disclosed |
| EP-0005823-A1 | Leak-proof alkaline cell and its production | Hitachi Maxell Ltd. (JP) | 1979-12-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540893-B2 | Mass cytometry reagents and methods for signal amplification | CD47, HLCS, SRMS | PLAU 3843/4885KDM4E 3700/4885ALDH1A1 2358/4885 |
| US-20260133115-A1 | MASS CYTOMETRY REAGENTS AND METHODS FOR SIGNAL AMPLIFICATION | SRMS, THOC2, TSPO | PLAU 3768/4885KDM4E 4355/4885ALDH1A1 2892/4885 |
| US-20250353855-A1 | HETEROCYCLIC AND HETEROARYL COMPOUNDS FOR TREATING HUNTINGTON'S DISEASE | HTT, HYPK, FH | PLAU 4058/4885KDM4E 3648/4885ALDH1A1 1719/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.